IRADIMED CORP
For the period ended Dec 31, 2025. Filed Mar 6, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 6, 2026
IRMD$86.94+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Stockholders’ Equity
| | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | | | | | | | | | | | | | | | | |
| · · · · · · · · · Additional · · · · · | ||||||||||||||||
| · · · · Common Stock · · Paid-in · · Retained · · Stockholders’ | ||||||||||||||||
| · · · · Shares · · Amount · · Capital · · Earnings · · Equity | ||||||||||||||||
| Balances, December 31, 2023 | | | 12,660 | $1 | $28,161 | $43,258 | $71,420 | |||||||||
| Net income | | | — | | | — | | | — | | | 19,234 | | | 19,234 | |
| Dividends declared | | | — | | | — | | | — | | | (5,701) | | | (5,701) | |
| Stock-based compensation expense | | | — | | | — | | | 2,524 | | | — | | | 2,524 | |
| Net share settlement of restricted stock units | | | 40 | | | — | | | (557) | | | — | | | (557) | |
| Net share settlement of performance based stock units | | | | 7 | | | — | | | (131) | | | — | | | (131) |
| Exercise of stock options | | | 3 | | | — | | | 30 | | | — | | | 30 | |
| Balances, December 31, 2024 | | | 12,710 | $1 | $30,027 | $56,791 | $86,819 | |||||||||
| Net income | | | — | | | — | | | — | | | 22,480 | | | 22,480 | |
| Dividends declared | | | — | | | — | | | — | | | (15,040) | | | (15,040) | |
| Stock-based compensation expense | | | — | | | — | | | 2,919 | | | — | | | 2,919 | |
| Net share settlement of restricted stock units | | | 47 | | | — | | | (1,429) | | | — | | | (1,429) | |
| Net share settlement of performance based stock units | | | | 25 | | | — | | | (1,131) | | | — | | | (1,131) |
| Balances, December 31, 2025 | | | 12,782 | $1 | $30,386 | $64,231 | $94,618 | |||||||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.